4-((5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl)methyl)morpholine, 95.0%, 250mg

Pentaethylene Glycol Monododecyl Ether>98.0%(GC)5g

Nalpha-(tert-Butoxycarbonyl)-N1-formyl-L-tryptophan>98.0%(T)5g

2-Benzyloxy-5-fluorophenylboronic acid, 95.0%, 1g

3-Fluorobenzyl Alcohol>97.0%(GC)25g

Methyl Diethylphosphonoacetate>96.0%(GC)5g

Ethyl 1-(2-ethoxy-2-oxoethyl)-2-oxocyclopentane-1-carboxylate, 95+%, 250mg

8-Fluoro-5-nitroquinoline, 95.0%, 5g

Tetrabutylammonium Borohydride [Reducing Reagent]>96.0%(T)25g

(1-Ethyl-1H-pyrazol-5-yl)boronic acid, 95.0%, 250mg

2-Fluoro-4-(trifluoromethyl)benzyl alcohol, 97.0%, 100mg

3-[[3,5-Bis(trifluoromethyl)phenyl]amino]-4-[[(1S,2S)-2-(dimethylamino)cyclohexyl]amino]-3-cyclobutene-1,2-dione, 97%, 1g

Ethyl 2-((trans-4-(4-(bromomethyl)phenyl)cyclohexyl)acetate, 97%, 1g